MOTS-C Research Overview

MOTS-C Research Overview: What the Literature Says

MOTS-C is a 16-amino-acid mitochondrial-derived peptide, encoded within a short open reading frame in the mitochondrial 12S rRNA region rather than nuclear DNA. Among research compounds, it represents a relatively newer discovery, first characterized in 2015, and has since become a significant focus of metabolic research.

Discovery and Background

MOTS-C belongs to a class of compounds known as mitochondrial-derived peptides (MDPs), which also includes humanin and SHLP2. The identification of a short open reading frame in mitochondrial DNA encoding humanin suggested the existence of additional mitochondrial-encoded signaling molecules, leading researchers to characterize this compound. This established a paradigm-shifting concept: that mitochondria act not only as metabolic organelles but as active signaling units producing their own regulatory molecules.

What the Research Covers

In animal models, MOTS-C is commonly researched for its potential role in several areas:

• Cellular energy metabolism — studied for its role in regulating metabolic homeostasis, with research indicating its primary target tissue is skeletal muscle.
• Insulin sensitivity — research in diet-induced obese mouse models has examined its interaction with glucose metabolism, with studies reporting improved insulin-stimulated glucose disposal and AMPK activation in skeletal muscle.
• Exercise-related physiology — studies have explored how its levels and activity relate to metabolic adaptation, including its effects on the folate cycle and de novo purine biosynthesis pathways.
• Plasma metabolite regulation — metabolomics research has examined its effects on sphingolipid, monoacylglycerol, and dicarboxylate metabolism pathways relevant to metabolic syndrome research models.

The foundational research characterizing this compound demonstrated its effects using diet-induced obese mouse models, establishing its role in regulating insulin sensitivity and metabolic homeostasis. For a detailed look at this original research, see: The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance (Cell Metabolism).

As a mitochondrial-derived peptide, it represents a relatively newer area of peptide research compared to more established compounds, with an actively growing body of published literature examining its mechanisms in animal and cell culture models.

Purity Considerations

HPLC-verified purity and mass spectrometry identity confirmation help ensure research consistency across batches. Consult the published documentation for the specific sample.

Handling and Reconstitution

MOTS-C is supplied in lyophilized form and requires reconstitution with an appropriate diluent before use in a research application. See our Reconstitution Guide for general laboratory technique.

Frequently Referenced Study Areas for These Research Peptides

Researchers studying MOTS-C often reference it alongside other mitochondrial-derived compounds, particularly humanin and SHLP2, since these compounds share some overlapping signaling pathways (including AKT and ERK activation) while also exhibiting distinct, compound-specific effects. Comparative studies examining multiple MDPs side by side have helped clarify which metabolic effects are specific to this compound versus shared across the broader mitochondrial-derived peptide family.

Because circulating MOTS-C levels have been observed to decline alongside the development of insulin resistance in aging research models, it continues to be referenced in longevity and metabolic aging research as a marker of interest, alongside its more direct mechanistic study as an insulin-sensitizing compound.

Interest in mitochondrial-derived signaling molecules has grown alongside broader recognition that mitochondria function as active signaling hubs rather than purely energy-producing organelles. This shift in understanding has opened new directions for researchers studying cellular aging, metabolic disease models, and the relationship between mitochondrial function and whole-body energy regulation, with this peptide serving as one of the more well-characterized examples within this emerging peptide class.